Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Toll like-receptor agonist Pam3Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56.

Kennerknecht K, Noschka R, Löffler F, Wehrstedt S, Pedersen GK, Mayer D, Grieshober M, Christensen D, Stenger S.

Med Microbiol Immunol. 2020 Apr;209(2):163-176. doi: 10.1007/s00430-020-00657-3. Epub 2020 Feb 4.

2.

Volcanic mercury and mutagenesis in land plants during the end-Triassic mass extinction.

Lindström S, Sanei H, van de Schootbrugge B, Pedersen GK, Lesher CE, Tegner C, Heunisch C, Dybkjær K, Outridge PM.

Sci Adv. 2019 Oct 23;5(10):eaaw4018. doi: 10.1126/sciadv.aaw4018. eCollection 2019 Oct.

3.

Rational Design and In Vivo Characterization of Vaccine Adjuvants.

Schmidt ST, Pedersen GK, Christensen D.

ILAR J. 2018 Dec 31;59(3):309-322. doi: 10.1093/ilar/ily018.

4.

TACI expression and plasma cell differentiation are impaired in the absence of functional IκBNS.

Khoenkhoen S, Erikson E, Ádori M, Stark JM, Scholz JL, Cancro MP, Pedersen GK, Karlsson Hedestam GB.

Immunol Cell Biol. 2019 May;97(5):485-497. doi: 10.1111/imcb.12228. Epub 2019 Jan 30.

5.

Immunocorrelates of CAF family adjuvants.

Pedersen GK, Andersen P, Christensen D.

Semin Immunol. 2018 Oct;39:4-13. doi: 10.1016/j.smim.2018.10.003. Epub 2018 Nov 2. Review.

6.

Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.

Wilkinson A, Lattmann E, Roces CB, Pedersen GK, Christensen D, Perrie Y.

J Control Release. 2018 Dec 10;291:1-10. doi: 10.1016/j.jconrel.2018.10.002. Epub 2018 Oct 3.

7.

B-1a Cell Development in Splenectomized Neonatal Mice.

Pedersen GK, Li X, Khoenkhoen S, Ádori M, Beutler B, Karlsson Hedestam GB.

Front Immunol. 2018 Jul 30;9:1738. doi: 10.3389/fimmu.2018.01738. eCollection 2018.

8.

Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).

Schmidt ST, Pedersen GK, Neustrup MA, Korsholm KS, Rades T, Andersen P, Foged C, Christensen D.

Front Immunol. 2018 Apr 30;9:898. doi: 10.3389/fimmu.2018.00898. eCollection 2018.

9.

Altered Marginal Zone B Cell Selection in the Absence of IκBNS.

Ádori M, Pedersen GK, Ádori C, Erikson E, Khoenkhoen S, Stark JM, Choi JH, Dosenovic P, Karlsson MCI, Beutler B, Karlsson Hedestam GB.

J Immunol. 2018 Jan 15;200(2):775-787. doi: 10.4049/jimmunol.1700791. Epub 2017 Dec 8.

10.

PTIP chromatin regulator controls development and activation of B cell subsets to license humoral immunity in mice.

Su D, Vanhee S, Soria R, Gyllenbäck EJ, Starnes LM, Højfeldt MK, Pedersen GK, Yuan J, Daniel JA.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9328-E9337. doi: 10.1073/pnas.1707938114. Epub 2017 Oct 16.

11.

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice.

Ebensen T, Debarry J, Pedersen GK, Blazejewska P, Weissmann S, Schulze K, McCullough KC, Cox RJ, Guzmán CA.

Front Immunol. 2017 Sep 28;8:1223. doi: 10.3389/fimmu.2017.01223. eCollection 2017.

12.

Heterozygous Mutation in IκBNS Leads to Reduced Levels of Natural IgM Antibodies and Impaired Responses to T-Independent Type 2 Antigens.

Pedersen GK, Ádori M, Stark JM, Khoenkhoen S, Arnold C, Beutler B, Karlsson Hedestam GB.

Front Immunol. 2016 Mar 1;7:65. doi: 10.3389/fimmu.2016.00065. eCollection 2016.

13.

NF-κB signaling in B-1 cell development.

Pedersen GK, Ádori M, Karlsson Hedestam GB.

Ann N Y Acad Sci. 2015 Dec;1362:39-47. doi: 10.1111/nyas.12800. Epub 2015 Jun 11. Review.

PMID:
26096766
14.

Fagaceae pollen from the early Cenozoic of West Greenland: revisiting Engler's and Chaney's Arcto-Tertiary hypotheses.

Grímsson F, Zetter R, Grimm GW, Pedersen GK, Pedersen AK, Denk T.

Plant Syst Evol. 2015;301:809-832. Epub 2014 Aug 2.

15.

Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man.

Pedersen GK, Sjursen H, Nøstbakken JK, Jul-Larsen Å, Hoschler K, Cox RJ.

Hum Vaccin Immunother. 2014;10(8):2408-16. doi: 10.4161/hv.29583.

16.

Slc15a4 function is required for intact class switch recombination to IgG2c in response to TLR9 stimulation.

Dosenovic P, Ádori M, Adams WC, Pedersen GK, Soldemo M, Beutler B, Karlsson Hedestam GB.

Immunol Cell Biol. 2015 Feb;93(2):136-46. doi: 10.1038/icb.2014.82. Epub 2014 Oct 14.

PMID:
25310967
17.

B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS.

Pedersen GK, Àdori M, Khoenkhoen S, Dosenovic P, Beutler B, Karlsson Hedestam GB.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):E4119-26. doi: 10.1073/pnas.1415866111. Epub 2014 Sep 16.

18.

HIV-1 Env-specific memory and germinal center B cells in C57BL/6 mice.

Soldemo M, Pedersen GK, Karlsson Hedestam GB.

Viruses. 2014 Sep 5;6(9):3400-14. doi: 10.3390/v6093400.

19.

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.

Pedersen GK, Höschler K, Øie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ.

Vaccine. 2014 Jul 31;32(35):4550-7. doi: 10.1016/j.vaccine.2014.06.009. Epub 2014 Jun 18.

PMID:
24950357
20.

Reply to Sambhara.

Bredholt G, Pedersen GK, Pathirana RD, Akselsen PE, Jane Cox R.

J Infect Dis. 2013 Apr;207(7):1186-8. doi: 10.1093/infdis/jit014. Epub 2013 Jan 10. No abstract available.

PMID:
23307933
21.

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

Svindland SC, Pedersen GK, Pathirana RD, Bredholt G, Nøstbakken JK, Jul-Larsen Å, Guzmán CA, Montomoli E, Lapini G, Piccirella S, Jabbal-Gill I, Hinchcliffe M, Cox RJ.

Influenza Other Respir Viruses. 2013 Nov;7(6):1181-93. doi: 10.1111/irv.12056. Epub 2012 Nov 21.

22.

A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination.

Pathirana RD, Bredholt G, Akselsen PE, Pedersen GK, Cox RJ.

J Infect Dis. 2012 Dec 1;206(11):1660-9. doi: 10.1093/infdis/jis589. Epub 2012 Sep 11.

PMID:
22969149
23.

T-helper 1 cells elicited by H5N1 vaccination predict seroprotection.

Pedersen GK, Madhun AS, Breakwell L, Hoschler K, Sjursen H, Pathirana RD, Goudsmit J, Cox RJ.

J Infect Dis. 2012 Jul 15;206(2):158-66. doi: 10.1093/infdis/jis330. Epub 2012 May 2.

PMID:
22551811
24.

Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP.

Pedersen GK, Ebensen T, Gjeraker IH, Svindland S, Bredholt G, Guzmán CA, Cox RJ.

PLoS One. 2011;6(11):e26973. doi: 10.1371/journal.pone.0026973. Epub 2011 Nov 1.

25.

Posterior capsule opacification and neodymium: YAG capsulotomy with heparin-surface-modified intraocular lenses.

Winther-Nielson A, Johansen J, Pedersen GK, Corydon L.

J Cataract Refract Surg. 1998 Jul;24(7):940-4.

PMID:
9682114
26.

Lifting derivations from quotients of separable C-algebras.

Pedersen GK.

Proc Natl Acad Sci U S A. 1976 May;73(5):1414-5.

27.

The "up-down" problem for operator algebras.

Pedersen GK.

Proc Natl Acad Sci U S A. 1971 Aug;68(8):1896-7.

Supplemental Content

Loading ...
Support Center